Chemical Component Summary

NameALISKIREN
Identifiers(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxo-propyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-yl-nonanamide
FormulaC30 H53 N3 O6
Molecular Weight551.76
TypeNON-POLYMER
Isomeric SMILESCOCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)ccc1OC
InChIInChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1
InChIKeyUXOWGYHJODZGMF-QORCZRPOSA-N

Chemical Details

Formal Charge0
Atom Count92
Chiral Atom Count4
Bond Count92
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB09026 
NameAliskiren
Groups
  • approved
  • investigational
DescriptionAliskiren is the first drug in the renin inhibitor drug class and is used for the treatment of hypertension.[A203624] It was developed by Speedel and Novartis and initially approved by the FDA in early 2007.[L14018] Aliskiren has been proven to efficacious in reducing blood pressure when used alone or in conjunction with other antihypertensive agents.[A203624]
Synonyms
  • Aliskiren
  • Aliskiren hemifumarate
  • Aliskireno
Brand Names
  • Rasilez HCT
  • Sandoz Aliskiren
  • Tekamlo
  • Valturna
  • Amturnide
IndicationAliskiren is used for the treatment of hypertension in children above 6 years and adults.[L13994] This drug may also be used in conjunction with antihypertensives such as calcium channel blockers and thiazides in products form to provide additional blood pressure control.[L14168,L14171]
Categories
  • Acids, Acyclic
  • Agents Acting on the Renin-Angiotensin System
  • Agents causing hyperkalemia
  • Antihypertensive Agents
  • Antihypertensive Agents Indicated for Hypertension
ATC-Code
  • C09XA54
  • C09XA53
  • C09DX02
  • C09XA02
  • C09XA52
CAS number173334-57-1

Drug Targets

NameTarget SequencePharmacological ActionActions
ReninMDGWRRMPRWGLLLLLWGSCTFGLPTDTTTFKRIFLKRMPSIRESLKERG...unknowninhibitor
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
P-glycoprotein 1MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682